Hein R - Search Results

1

Characterization of selected strongly and weakly invasive sublines of a primary human melanoma cell line and isolation of subtractive cDNA clones.

Jacob K, Bosserhoff AK, Wach F, Knüchel R, Klein EC, Hein R, Buettner R. Jacob K, et al. Among authors: hein r. Int J Cancer. 1995 Mar 3;60(5):668-75. doi: 10.1002/ijc.2910600517. Int J Cancer. 1995. PMID: 7532159

2

In vitro modulation of human melanoma cell invasion and proliferation by all-trans-retinoic acid.

Jacob K, Wach F, Holzapfel U, Hein R, Lengyel E, Buettner R, Bosserhoff AK. Jacob K, et al. Among authors: hein r. Melanoma Res. 1998 Jun;8(3):211-9. doi: 10.1097/00008390-199806000-00003. Melanoma Res. 1998. PMID: 9664142

3

[MIA ("melanoma inhibitory activity"). Biological functions and clinical relevance in malignant melanoma].

Bosserhoff AK, Golob M, Buettner R, Landthaler M, Hein R. Bosserhoff AK, et al. Among authors: hein r. Hautarzt. 1998 Oct;49(10):762-9. doi: 10.1007/s001050050822. Hautarzt. 1998. PMID: 9857251 Review. German.

4

Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR.

Mühlbauer M, Langenbach N, Stolz W, Hein R, Landthaler M, Buettner R, Bosserhoff AK. Mühlbauer M, et al. Among authors: hein r. Clin Cancer Res. 1999 May;5(5):1099-105. Clin Cancer Res. 1999. PMID: 10353744

5

Comparison of migration and invasiveness of epithelial tumor and melanoma cells in vitro.

Wach F, Eyrich AM, Wustrow T, Krieg T, Hein R. Wach F, et al. Among authors: hein r. J Dermatol Sci. 1996 Jun;12(2):118-26. doi: 10.1016/0923-1811(95)00470-x. J Dermatol Sci. 1996. PMID: 8814543

6

MIA (melanoma inhibitory activity): a potential serum marker for rheumatoid arthritis.

Müller-Ladner U, Bosserhoff AK, Dreher K, Hein R, Neidhart M, Gay S, Schölmerich J, Buettner R, Lang B. Müller-Ladner U, et al. Among authors: hein r. Rheumatology (Oxford). 1999 Feb;38(2):148-54. doi: 10.1093/rheumatology/38.2.148. Rheumatology (Oxford). 1999. PMID: 10342628

7

In situ expression patterns of melanoma-inhibiting activity (MIA) in melanomas and breast cancers.

Bosserhoff AK, Moser M, Hein R, Landthaler M, Buettner R. Bosserhoff AK, et al. Among authors: hein r. J Pathol. 1999 Mar;187(4):446-54. doi: 10.1002/(SICI)1096-9896(199903)187:4<446::AID-PATH267>3.0.CO;2-Y. J Pathol. 1999. PMID: 10398105

8

MIA, a novel serum marker for progression of malignant melanoma.

Bosserhoff AK, Lederer M, Kaufmann M, Hein R, Stolz W, Apfel R, Bogdahn U, Buettner R. Bosserhoff AK, et al. Among authors: hein r. Anticancer Res. 1999 Jul-Aug;19(4A):2691-3. Anticancer Res. 1999. PMID: 10470221

9

Comparison of two prognostic markers for malignant melanoma: MIA and S100 beta.

Juergensen A, Holzapfel U, Hein R, Stolz W, Buettner R, Bosserhoff A. Juergensen A, et al. Among authors: hein r. Tumour Biol. 2001 Jan-Feb;22(1):54-8. doi: 10.1159/000030147. Tumour Biol. 2001. PMID: 11054027

10

Melanoma inhibitory activity (MIA), a serological marker of malignant melanoma.

Bosserhoff AK, Dreau D, Hein R, Landthaler M, Holder WD, Buettner R. Bosserhoff AK, et al. Among authors: hein r. Recent Results Cancer Res. 2001;158:158-68. doi: 10.1007/978-3-642-59537-0_16. Recent Results Cancer Res. 2001. PMID: 11092043

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

385 results

Search Page

Filters